OptiNose, Inc.
OptiNose, Inc., a pioneering biopharmaceutical company headquartered in the United States, focuses on innovative solutions for patients suffering from chronic sinusitis and other nasal conditions. Founded in 2010, OptiNose has made significant strides in the industry, particularly with its unique delivery systems that enhance the efficacy of medications. The company’s flagship products, including the Xhance nasal spray, leverage advanced technology to improve drug absorption and patient compliance. With a commitment to addressing unmet medical needs, OptiNose has established a strong market position, recognised for its contributions to the field of nasal therapeutics. As it continues to expand its operational reach, OptiNose remains dedicated to transforming the treatment landscape for patients worldwide.
DitchCarbon Score
How does OptiNose, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
OptiNose, Inc.'s score of 25 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
OptiNose, Inc.'s reported carbon emissions
OptiNose, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a result, OptiNose's climate commitments and initiatives remain unclear, and there is no inherited emissions data from a parent or related organisation. The company has not established any Science-Based Targets Initiative (SBTi) reduction targets or other industry-standard climate commitments at this time. In the context of the pharmaceutical industry, where OptiNose operates, many companies are increasingly focusing on sustainability and carbon reduction strategies. However, without specific data or commitments from OptiNose, it is challenging to assess their position in this evolving landscape.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
OptiNose, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
